JPM
JPMorgan Chase & Co.
JPM's fundamentals are strong, but it looks expensive: trading at 14x earnings, above its usual 12x. Analysts expect earnings growth.
SLQT
SelectQuote, Inc.
There isn't enough reported data to score SLQT yet.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
SLQT Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| N/A | |
| N/A |
SLQT's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like SLQT.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
SLQT PE Valuation
SLQT has no meaningful PE right now: it lost money over the past year.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
JPM has the edge over SLQT on the outlook, with more favorable earnings and revenue expectations.
SLQT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Decline | |
| Weakening | |
| Limited | |
| High |
Analysts expect SLQT's revenue and profitability to decline, with its earnings holding steady.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the stronger earnings trend. Trailing diluted EPS is up 18% for JPM versus SLQT down 104%.
SLQT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q1 2025 | -$0.10 | +$0.22 |
| Q4 2024 | -$0.08 | +$0.23 |
| Q3 2024 | -$0.27 | +$0.01 |
| Q2 2024 | -$0.20 | +$0.15 |
| Q1 2024 | -$0.32 | +$0.38 |
| Q4 2023 | -$0.31 | +$0.49 |
| Q3 2023 | -$0.28 | +$1.50 |
| Q2 2023 | -$0.35 | +$1.45 |
SLQT is still losing money, but far less than before: $0.01 per share over the past year, against $1.80 at its worst in mid-2022.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over SLQT on profitability, with a higher operating margin.
SLQT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $280M | -15% |
| Q2 2026 | $321.7M | -6.8% |
| Q1 2026 | $430.9M | +5.6% |
| Q4 2025 | $537.1M | +12% |
| Q3 2025 | $328.8M | +13% |
| Q2 2025 | $345.1M | +12% |
| Q1 2025 | $408.2M | +8.4% |
| Q4 2024 | $481.1M | +19% |
SLQT's revenue grew through 2024 and has held roughly level since: $280M last quarter, down 15% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -10% | +2.2 points |
| Q2 2026 | 1.1% | +4.7 points |
| Q1 2026 | 8.3% | +2.9 points |
| Q4 2025 | 14% | -0.7 points |
| Q3 2025 | -12% | -8.3 points |
| Q2 2025 | -3.6% | -3.2 points |
| Q1 2025 | 5.4% | -3.4 points |
| Q4 2024 | 15% | +1.1 points |
SLQT's operating margin was −10% last quarter, up 2.2 points from the same quarter a year ago.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
SLQT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$17.8M | +$4.8M |
| Q2 2026 | -$4.5M | +$33.5M |
| Q1 2026 | $55.8M | -20% |
| Q4 2025 | -$1M | +$28M |
| Q3 2025 | -$22.7M | -$5.6M |
| Q2 2025 | -$38M | -293% |
| Q1 2025 | $70.2M | +62% |
| Q4 2024 | -$29M | -$2M |
SLQT has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over SLQT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
SLQT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.7% | +3.3M shares |
| 1 year | +3% | +5.6M shares |
| 3 years | +14% | +24M shares |
| 5 years | +17% | +27.8M shares |
| Available history | +39% | +53.3M shares |
SLQT has 191M diluted shares, up 3% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2020 | — |
| Q4 2019 | — |
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM has the edge over SLQT on leverage, with a lower net debt burden relative to earnings.
SLQT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.6x | Elevated |
| Q2 2026 | 3.9x | Elevated |
| Q1 2026 | 4.6x | High |
| Q4 2025 | 6.2x | High |
| Q3 2025 | 6.5x | High |
| Q2 2025 | 4.0x | Elevated |
| Q1 2025 | 3.1x | Elevated |
| Q4 2024 | 6.2x | High |
SLQT's net debt is about 3.6 years of its operating earnings (EBITDA), down from 6.5 years a year ago. Net leverage isn't a meaningful measure for financial services companies like SLQT.
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
SLQT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.3 | Neutral |
| Stochastic | 23.9 | Neutral |
SLQT's weekly RSI is 42 (neutral) and its Stochastic is 24 (neutral).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
SLQT PE vs Financial Services Sector
| Metric | SLQT | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
SLQT has no meaningful PE right now: it lost money over the past year.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over SLQT on trend strength, trading above more of its moving averages.
SLQT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.39 | 26% above |
| 20 week MA | $0.55 | 11% below |
| 50 week MA | $0.84 | 42% below |
| 100 week MA | $1.81 | 73% below |
| 200 week MA | $1.90 | 74% below |
SLQT has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 74% below its 200-week average.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over SLQT on returns for 2026, with the stronger performance.
SLQT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $26.5 | $22.3 | -16% |
| 2021 | $22.3 | $9.38 | -58% |
| 2022 | $9.38 | $0.65 | -93% |
| 2023 | $0.65 | $1.37 | +111% |
| 2024 | $1.37 | $3.68 | +169% |
| 2025 | $3.68 | $1.37 | -63% |
| 2026 YTD | $1.37 | $0.49 | -64% |
SLQT's yearly returns have swung widely, from +169% in 2024 to −93% in 2022. It's down 64% so far in 2026.